The object of the study were 65 patients with stage 1–2 hypertension in combination with cronic obstructive pulmonary disease (COPD) stage 1–2 in remission, with a mean age (58.89±3.65) years. All patients were divided into two groups. For the treatment of hypertension with concomitant COPD, patients of the 1st group were administered verapamil and sydnofarm; patients of the 2nd group on the first day additionally received nebulizer bronchodilator therapy and on the second one — low-intensity laser radiation (LILR).
Appointment to the background drug therapy from the first day of treatment bronchodilator nebulizer therapy, and the second day — LILR for patients with hypertension stage 1–2 with concomitant COPD in remission, allowed to improve bronchial patency, thereby reducing hypoxia, effectively decreased high blood pressure, increased exercise tolerance. The patients who have been appointed only standard medical therapy, the obtained values had no significant differences.
Complex of drug and non-drug treatments for hypertension in combination with COPD, including verapamil, sydnofarm, nebulizer bronchodilator therapy and LILR is pathogenetically justified and appropriate in terms of improving the quality of life for patients.